Jeremy McConnell

Dr. Atul Malhotra, lead investigator of the SURMOUNT-OSA trial, joins specialists Dr. Radhika Breaden, Dr. Jeremy McConnell, and Dr. Rafael Sepulveda Acosta to discuss the groundbreaking FDA approval of tirzepatide for obstructive sleep apnea. They delve into its effectiveness beyond weight loss, practical implementation strategies for clinics, and the importance of managing associated conditions like obesity. The team addresses concerns about GLP-1 medications and emphasizes collaboration between sleep and obesity medicine to provide comprehensive care for patients.